The Lancet Oncology, 1474-5488

Journal

More filtering options
  1. 2019
  2. Health-related quality of life after apalutamide treatment in patients with metastatic castration-sensitive prostate cancer (TITAN): a randomised, placebo-controlled, phase 3 study

    TITAN Investigators, Agarwal, N., McQuarrie, K., Bjartell, A., Chowdhury, S., Pereira de Santana Gomes, A. J., Chung, B. H., Özgüroğlu, M., Juárez Soto, Á., Merseburger, A. S., Uemura, H., Ye, D., Given, R., Cella, D., Basch, E., Miladinovic, B., Dearden, L., Deprince, K., Naini, V., Lopez-Gitlitz, A. & 1 othersChi, K. N., 2019, In : The Lancet Oncology. 20, 11, p. 1518-1530 13 p.

    Research output: Contribution to journalArticle

  3. Risk of complications in patients with conservatively managed ovarian tumours (IOTA5): a 2-year interim analysis of a multicentre, prospective, cohort study

    Froyman, W., Landolfo, C., De Cock, B., Wynants, L., Sladkevicius, P., Testa, A. C., Van Holsbeke, C., Domali, E., Fruscio, R., Epstein, E., dos Santos Bernardo, M. J., Franchi, D., Kudla, M. J., Chiappa, V., Alcazar, J. L., Leone, F. P. G., Buonomo, F., Hochberg, L., Coccia, M. E., Guerriero, S. & 10 othersDeo, N., Jokubkiene, L., Kaijser, J., Coosemans, A., Vergote, I., Verbakel, J. Y., Bourne, T., Van Calster, B., Lil Valentin & Timmerman, D., 2019, In : The Lancet Oncology. 20, 3, p. 448-458 11 p.

    Research output: Contribution to journalArticle

  4. Tomosynthesis in breast screening: great expectations?

    Sophia Zackrisson, 2019, In : The Lancet. Oncology. 20, 6, p. 745-746 2 p.

    Research output: Contribution to journalArticle

  5. 2018
  6. Discontinuation of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia (EURO-SKI): a prespecified interim analysis of a prospective, multicentre, non-randomised, trial

    Saussele, S., Richter, J., Guilhot, J., Gruber, F. X., Hjorth-Hansen, H., Almeida, A., Janssen, J. J. W. M., Mayer, J., Koskenvesa, P., Panayiotidis, P., Olsson-Strömberg, U., Martinez-Lopez, J., Rousselot, P., Vestergaard, H., Ehrencrona, H., Kairisto, V., Machová Poláková, K., Müller, M. C., Mustjoki, S., Berger, M. G. & 6 othersFabarius, A., Hofmann, W. K., Hochhaus, A., Pfirrmann, M., Mahon, F. X. & EURO-SKI investigators, 2018 Jun, In : The Lancet Oncology. 19, 6, p. 747-757

    Research output: Contribution to journalArticle

  7. Quality of life in patients with recurrent ovarian cancer treated with niraparib versus placebo (ENGOT-OV16/NOVA): results from a double-blind, phase 3, randomised controlled trial

    Oza, A. M., Matulonis, U. A., Malander, S., Hudgens, S., Sehouli, J., del Campo, J. M., Berton-Rigaud, D., Banerjee, S., Scambia, G., Berek, J. S., Lund, B., Tinker, A. V., Hilpert, F., Vázquez, I. P., D'Hondt, V., Benigno, B., Provencher, D., Buscema, J., Agarwal, S. & Mirza, M. R., 2018, In : The Lancet Oncology. 19, 8, p. 1117-1125 9 p.

    Research output: Contribution to journalArticle

  8. 2017
  9. The drama of prostate cancer diagnostics

    Ola Bratt, Hugosson, J., Klotz, L. & Gnanapragasam, V., 2017 Mar 1, In : The Lancet Oncology. 18, 3, p. e132

    Research output: Contribution to journalLetter

  10. Recommendations for gonadotoxicity surveillance in male childhood, adolescent, and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCareSurFup Consortium

    Skinner, R., Mulder, R. L., Kremer, L. C. M., Hudson, M. M., Constine, L. S., Bardi, E., Boekhout, A., Borgmann-Staudt, A., Brown, M. C., Cohn, R., Dirksen, U., Giwercman, A., Ishiguro, H., Jahnukainen, K., Kenney, L. B., Loonen, J. J., Meacham, L., Neggers, S. J., Nussey, S., Petersen, C. & 5 othersShnorhavorian, M., van den Heuvel-Eibrink, M. M., Van Santen, H. M., Wallace, W. H. B. & Green, D. M., 2017 Feb 1, In : The Lancet Oncology. 18, 2, p. e75-e90

    Research output: Contribution to journalReview article

  11. Role of radiotherapy fractionation in head and neck cancers (MARCH): an updated meta-analysis

    MARCH Collaborative Group, 2017 Jan 1, In : The Lancet Oncology. 18, 9, p. 1221-1237 17 p.

    Research output: Contribution to journalArticle

  12. Genetics of gallbladder cancer

    Kari Hemminki, Hemminki, A., Asta Försti, Kristina Sundquist & Xinjun Li, 2017, In : The Lancet Oncology. 18, 6, p. e296 1 p.

    Research output: Contribution to journalLetter

  13. Optimal fractionation of preoperative radiotherapy and timing to surgery for rectal cancer (Stockholm III): A multicentre, randomised, non-blinded, phase 3, non-inferiority trial

    Erlandsson, J., Holm, T., Pettersson, D., Berglund, Å., Cedermark, B., Radu, C., Johansson, H., Machado, M., Hjern, F., Hallböök, O., Ingvar Syk, Glimelius, B. & Martling, A., 2017, In : The Lancet Oncology. 18, 3, p. 336-346

    Research output: Contribution to journalArticle

  14. Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer (CLIN1001 PCM301): An open-label, phase 3, randomised controlled trial

    Azzouzi, A. R., Vincendeau, S., Barret, E., Cicco, A., Kleinclauss, F., van der Poel, H. G., Stief, C. G., Rassweiler, J., Salomon, G., Solsona, E., Alcaraz, A., Tammela, T. T., Rosario, D. J., Gomez-Veiga, F., Ahlgren, G., Benzaghou, F., Gaillac, B., Amzal, B., Debruyne, F. M. J., Fromont, G. & 2 othersGratzke, C. & Emberton, M., 2017, In : The Lancet Oncology. 18, 2, p. 181-191

    Research output: Contribution to journalArticle

  15. 2016
  16. Morcellation and risk of malignancy in presumed ovarian fibromas/fibrothecomas

    Froyman, W., Landolfo, C., Amant, F., Van den Bosch, T., Vergote, I., Coosemans, A., Testa, A., Lil Valentin, Bourne, T., Calster, B. V. & Timmerman, D., 2016 Mar, In : The Lancet Oncology. 17, 3, p. 273-4 2 p.

    Research output: Contribution to journalDebate/Note/Editorial

  17. Standard first-line chemotherapy with or without nintedanib for advanced ovarian cancer (AGO-OVAR 12): a randomised, double-blind, placebo-controlled phase 3 trial.

    Bois, A. D., Kristensen, G., Ray-Coquard, I., Reuss, A., Pignata, S., Colombo, N., Denison, U., Vergote, I., Del Campo, J. M., Ottevanger, P., Heubner, M., Minarik, T., Sevin, E., de Gregorio, N., Bidziński, M., Pfisterer, J., Malander, S., Hilpert, F., Mirza, M. R., Scambia, G. & 7 othersMeier, W., Nicoletto, M. O., Bjørge, L., Lortholary, A., Sailer, M. O., Merger, M. & Harter, P., 2016, In : The Lancet Oncology. 17, 1, p. 78-89

    Research output: Contribution to journalArticle

  18. 2015
  19. Endometrial cancer and oral contraceptives: an individual participant meta-analysis of 27 276 women with endometrial cancer from 36 epidemiological studies

    Allen, N., Yang, TO., Håkan Olsson & Collaborative Group on Epidemiological Studies on Endometrial Cancer, 2015 Sep, In : The Lancet. Oncology. 16, 9, p. 1061-1070

    Research output: Contribution to journalArticle

  20. Global cancer surgery: delivering safe, affordable, and timely cancer surgery

    Sullivan, R., Alatise, O. I., Anderson, B. O., Audisio, R., Autier, P., Aggarwal, A., Balch, C., Brennan, M. F., Dare, A., D'Cruz, A., Eggermont, A. M. M., Fleming, K., Gueye, S. M., Hagander, L., Herrera, C. A., Holmer, H., Ilbawi, A., Jarnheimer, A., Ji, J., Kingham, T. P. & 23 othersLiberman, J., Leather, A. J. M., Meara, J. G., Mukhopadhyay, S., Murthy, S. S., Omar, S., Parham, G. P., Pramesh, C. S., Riviello, R., Rodin, D., Santini, L., Shrikhande, S. V., Shrime, M., Thomas, R., Tsunoda, A. T., van de Velde, C., Veronesi, U., Vijaykumar, D. K., Watters, D., Wang, S., Wu, Y-L., Zeiton, M. & Purushotham, A., 2015, In : The Lancet Oncology. 16, 11, p. 1193-1224

    Research output: Contribution to journalArticle

  21. Towards "next-generation" prostate cancer screening.

    Lamb, A. D. & Ola Bratt, 2015, In : The Lancet Oncology. 16, 16, p. 1579-1580

    Research output: Contribution to journalDebate/Note/Editorial

  22. Vorinostat in patients with advanced malignant pleural mesothelioma who have progressed on previous chemotherapy (VANTAGE-014): a phase 3, double-blind, randomised, placebo-controlled trial.

    Krug, L. M., Kindler, H. L., Calvert, H., Manegold, C., Tsao, A. S., Fennell, D., Öhman, R., Plummer, R., Eberhardt, W. E. E., Fukuoka, K., Gaafar, R. M., Lafitte, J-J., Hillerdal, G., Chu, Q., Buikhuisen, W. A., Lubiniecki, G. M., Sun, X., Smith, M. & Baas, P., 2015, In : The Lancet Oncology. 16, 4, p. 447-456

    Research output: Contribution to journalArticle

  23. 2014
  24. Local treatments for metastases of renal cell carcinoma: a systematic review

    Saeed Dabestani, Marconi, L., Hofmann, F., Stewart, F., Lam, T. B. L., Canfield, S. E., Staehler, M., Powles, T., Ljungberg, B. & Bex, A., 2014, In : The Lancet Oncology. 15, 12, p. E549-E561

    Research output: Contribution to journalReview article

  25. Prevention and early detection of prostate cancer.

    Cuzick, J., Thorat, M. A., Andriole, G., Brawley, O. W., Brown, P. H., Culig, Z., Eeles, R. A., Ford, L. G., Hamdy, F. C., Holmberg, L., Ilic, D., Key, T. J., Vecchia, C. L., Lilja, H., Marberger, M., Meyskens, F. L., Minasian, L. M., Parker, C., Parnes, H. L., Perner, S. & 9 othersRittenhouse, H., Schalken, J., Schmid, H-P., Schmitz-Dräger, B. J., Schröder, F. H., Stenzl, A., Tombal, B., Wilt, T. J. & Wolk, A., 2014, In : The Lancet Oncology. 15, 11, p. E484-E492

    Research output: Contribution to journalReview article

  26. 2013
  27. Air pollution and lung cancer incidence in 17 European cohorts: Prospective analyses from the European Study of Cohorts for Air Pollution Effects (ESCAPE)

    Raaschou-Nielsen, O., Andersen, Z. J., Beelen, R., Samoli, E., Stafoggia, M., Weinmayr, G., Hoffmann, B., Fischer, P., Nieuwenhuijsen, M. J., Brunekreef, B., Xun, W. W., Katsouyanni, K., Dimakopoulou, K., Sommar, J., Forsberg, B., Modig, L., Oudin, A., Oftedal, B., Schwarze, P. E., Nafstad, P. & 39 othersDe Faire, U., Pedersen, N. L., Östenson, C. G., Fratiglioni, L., Penell, J., Korek, M., Pershagen, G., Eriksen, K. T., Sørensen, M., Tjønneland, A., Ellermann, T., Eeftens, M., Peeters, P. H., Meliefste, K., Wang, M., Bueno-de-Mesquita, B., Key, T. J., de Hoogh, K., Concin, H., Nagel, G., Vilier, A., Grioni, S., Krogh, V., Tsai, M. Y., Ricceri, F., Sacerdote, C., Galassi, C., Migliore, E., Ranzi, A., Cesaroni, G., Badaloni, C., Forastiere, F., Tamayo, I., Amiano, P., Dorronsoro, M., Trichopoulou, A., Bamia, C., Vineis, P. & Hoek, G., 2013 Aug, In : The Lancet Oncology. 14, 9, p. 813-822 10 p.

    Research output: Contribution to journalArticle

  28. Air pollution and lung cancer in Europe - Authors' reply

    Raaschou-Nielsen, O., Vineis, P., Brunekreef, B., Nieuwenhuijsen, M., Hoffmann, B., Forastiere, F., Anna Oudin, Hoek, G., Katsouyanni, K., Schwarze, P. & Beelen, R., 2013, In : The Lancet Oncology. 14, 11, p. e440

    Research output: Contribution to journalLetter

  29. Sustaining innovation and improvement in the treatment of childhood cancer: lessons from high-income countries

    Pritchard-Jones, K., Pieters, R., Reaman, G. H., Lars Hjorth, Downie, P., Calaminus, G., Naafs-Wilstra, M. C. & Steliarova-Foucher, E., 2013, In : The Lancet Oncology. 14, 3, p. E95-E103

    Research output: Contribution to journalArticle

  30. 2012
  31. Imatinib after induction for treatment of children and adolescents with Philadelphia-chromosome-positive acute lymphoblastic leukaemia (EsPhALL): a randomised, open-label, intergroup study

    Biondi, A., Schrappe, M., De Lorenzo, P., Anders Castor, Lucchini, G., Gandemer, V., Pieters, R., Stary, J., Escherich, G., Campbell, M., Li, C-K., Vora, A., Arico, M., Roettgers, S., Saha, V. & Valsecchi, M. G., 2012, In : The Lancet Oncology. 13, 9, p. 936-945

    Research output: Contribution to journalArticle

  32. Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies

    Collaborative Group on Hormonal Factors in Breast Cancer & Håkan Olsson, 2012, In : The Lancet Oncology. 13, 11, p. 1141-1151

    Research output: Contribution to journalArticle

  33. Ovarian cancer and smoking: individual participant meta-analysis including 28 114 women with ovarian cancer from 51 epidemiological studies

    Beral, V., Gaitskell, K., Hermon, C., Moser, K., Reeves, G., Peto, R., Brinton, L., Marchbanks, P., Negri, E., Ness, R., Peeters, P. H. M., Vessey, M., Calle, E. E., Gapstur, S. M., Patel, A. V., Dal Maso, L., Talamini, R., Chetrit, A., Hirsh-Yechezkel, G., Lubin, F. & 137 othersSadetzki, S., Banks, E., Beral, V., Bull, D., Callaghan, K., Crossley, B., Gaitskell, K., Goodill, A., Green, J., Hermon, C., Key, T., Moser, K., Reeves, G., Sitas, F., Collins, R., Doll, R., Peto, R., Gonzalez, A., Lee, N., Marchbanks, P., Ory, H. W., Peterson, H. B., Wingo, P. A., Martin, N., Pardthaisong, T., Silpisornkosol, S., Theetranont, C., Boosiri, B., Chutivongse, S., Jimakorn, P., Virutamasen, P., Wongsrichanalai, C., Tjonneland, A., Titus-Ernstoff, L., Byers, T., Rohan, T., Mosgaard, B. J., Vessey, M., Yeates, D., Freudenheim, J. L., Chang-Claude, J., Kaaks, R., Anderson, K. E., Folsom, A., Robien, K., Hampton, J., Newcomb, P. A., Rossing, M. A., Thomas, D. B., Weiss, N. S., Riboli, E., Clavel-Chapelon, F., Cramer, D., Hankinson, S. E., Tworoger, S. S., Franceschi, S., La Vecchia, C., Negri, E., Adami, H. O., Magnusson, C., Riman, T., Weiderpass, E., Wolk, A., Schouten, L. J., van den Brandt, P. A., Chantarakul, N., Koetsawang, S., Rachawat, D., Palli, D., Black, A., Brinton, L. A., Freedman, D. M., Hartge, P., Hsing, A. W., Lacey, J. V., Hoover, R. N., Schairer, C., Urban, M., Graff-Iversen, S., Selmer, R., Bain, C. J., Green, A. C., Purdie, D. M., Siskind, V., Webb, P. M., Moysich, K., McCann, S. E., Hannaford, P., Kay, C., Binns, C. W., Lee, A. H., Zhang, M., Ness, R. B., Nasca, P., Coogan, P. F., Palmer, J. R., Rosenberg, L., Kelsey, J., Paffenbarger, R., Whittemore, A., Katsouyanni, K., Trichopoulou, A., Trichopoulos, D., Tzonou, A., Dabancens, A., Martinez, L., Molina, R., Salas, O., Goodman, M. T., Lurie, G., Carney, M. E., Wilkens, L. R., Linda Werner Hartman, Jonas Manjer, Håkan Olsson, Grisso, J. A., Morgan, M., Wheeler, J. E., Bunker, C. H., Edwards, R. P., Modugno, F., Peeters, P. H. M., Casagrande, J., Pike, M. C., Ross, R. K., Wu, A. H., Miller, A. B., Kumle, M., Gram, I. T., Lund, E., McGowan, L., Shu, X. O., Zheng, W., Farley, T. M. M., Holck, S., Meirik, O. & Risch, H. A., 2012, In : The Lancet Oncology. 13, 9, p. 946-956

    Research output: Contribution to journalArticle

  34. Vandetanib in locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 2 trial

    Leboulleux, S., Bastholt, L., Krause, T., de la Fouchardiere, C., Jan Tennvall, Awada, A., Manuel Gomez, J., Bonichon, F., Leenhardt, L., Soufflet, C., Licour, M. & Schlumberger, M. J., 2012, In : The Lancet Oncology. 13, 9, p. 897-905

    Research output: Contribution to journalArticle

  35. 2010
  36. Effect of pamidronate 30 mg versus 90 mg on physical function in patients with newly diagnosed multiple myeloma (Nordic Myeloma Study Group): a double-blind, randomised controlled trial

    Gimsing, P., Carlson, K., Turesson, I., Fayers, P., Waage, A., Vangsted, A., Mylin, A., Gluud, C., Juliusson, G., Gregersen, H., Hjorth-Hansen, H., Nesthus, I., Dahl, I. M. S., Westin, J., Nielsen, J. L., Knudsen, L. M., Ahlberg, L., Hjorth, M., Abildgaard, N., Andersen, N. F. & 2 othersLinder, O. & Wisloeff, F., 2010, In : The Lancet Oncology. 11, 10, p. 973-982

    Research output: Contribution to journalArticle

  37. Mortality results from the Goteborg randomised population-based prostate-cancer screening trial

    Hugosson, J., Carlsson, S., Aus, G., Bergdahl, S., Khatami, A., Lodding, P., Pihl, C-G., Stranne, J., Holmberg, E. & Hans Lilja, 2010, In : The Lancet Oncology. 11, 8, p. 725-732

    Research output: Contribution to journalArticle

  38. Risk of thromboembolic diseases in men with prostate cancer: results from the population-based PCBaSe Sweden

    Van Hemelrijck, M., Adolfsson, J., Garmo, H., Bill-Axelson, A., Ola Bratt, Ingelsson, E., Lambe, M., Stattin, P. & Holmberg, L., 2010, In : The Lancet Oncology. 11, 5, p. 450-458

    Research output: Contribution to journalArticle

  39. 2009
  40. Familial risks in nervous-system tumours: a histology-specific analysis from Sweden and Norway

    Hemminki, K., Tretli, S., Jan Sundquist, Johannesen, T. B. & Granstrom, C., 2009, In : The Lancet Oncology. 10, 5, p. 481-488

    Research output: Contribution to journalArticle

  41. 2008
  42. Prognostic significance of maximum tumour (bulk) diameter in young patients with good-prognosis diffuse large-B-cell lymphoma treated with CHOP-like chemotherapy with or without rituximab: an exploratory analysis of the MabThera International Trial Group (MInT) study

    Pfreundschuh, M., Ho, A. D., Cavallin-Ståhl, E., Wolf, M., Pettengell, R., Vasova, I., Belch, A., Walewski, J., Zinzani, P-L., Mingrone, W., Kvaloy, S., Shpilberg, O., Jaeger, U., Hansen, M., Corrado, C., Scheliga, A., Loeffler, M. & Kuhnt, E., 2008, In : The Lancet Oncology. 9, 5, p. 435-444

    Research output: Contribution to journalArticle

  43. 2007
  44. Bone-targeted radium-223 in symptomatic, hormone-refractory prostate cancer: a randomised, multicentre, placebo-controlled phase II study

    Nilsson, S., Franzen, L., Parker, C., Tyrrell, C., Blom, R., Jan Tennvall, Lennernas, B., Petersson, U., Johannessen, D. C., Sokal, M., Pigott, K., Yachnin, J., Garkavij, M., Strang, P., Harmenberg, J., Bolstad, B. & Bruland, O. S., 2007, In : The Lancet Oncology. 8, 7, p. 587-594

    Research output: Contribution to journalArticle

  45. Reproductive risk factors for ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study

    McLaughlin, J. R., Risch, H. A., Lubinski, J., Moller, P., Ghadirian, P., Lynch, H., Karlan, B., Fishman, D., Rosen, B., Neuhausen, S. L., Offit, K., Kauff, N., Domchek, S., Tung, N., Friedman, E., Foulkes, W., Håkan Olsson & Hereditary Ovarian Cancer Clinical Study Group, A., 2007, In : The Lancet Oncology. 8, 1, p. 26-34

    Research output: Contribution to journalArticle

  46. 2006
  47. Should donors be allowed to give broad consent to future biobank research?

    Hansson, MG., Dillner, J., Bartrarn, CR., Joyce Carlson & Helgesson, G., 2006, In : The Lancet Oncology. 7, 3, p. 266-269

    Research output: Contribution to journalArticle

  48. Survival from rare cancer in adults: a population-based study

    Gatta, G., Ciccolallo, L., Kunkler, I., Capocaccia, R., Berrino, F., Coleman, MP., De Angelis, R., Faivre, J., Lutz, JM., Martinez, C., Möller, T. & Sankila, R., 2006, In : The Lancet Oncology. 7, 2, p. 132-140

    Research output: Contribution to journalArticle

  49. 2005
  50. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial

    Villa, LL., Costa, RLR., Petta, CA., Andrade, RP., Ault, KA., Giuliano, AR., Wheeler, CM., Koutsky, LA., Malm, C., Lehtinen, M., Skjeldestad, FE., Olsson, SE., Steinwall, M., Brown, DR., Kurman, R., Ronnett, BM., Stoler, MH., Ferenczy, A., Harper, DM., Tamms, GM. & 9 othersYu, J., Lupinacci, L., Railkar, R., Taddeo, FJ., Jansen, KU., Esser, MT., Sings, HL., Saah, AJ. & Lupinacci, L., 2005, In : The Lancet Oncology. 6, 5, p. 271-278

    Research output: Contribution to journalArticle

  51. 2002
  52. Genetic testing for melanoma

    Kefford, R., Newton Bishop, J., Tucker, M., Bressac--de Paillerets, B., Bianchi-Scarrá, G., Bergman, W., Goldstein, A., Puig, S., Mackie, R., Elder, D., Hansson, J., Hayward, N., Hogg, D. & Håkan Olsson, 2002, In : The Lancet Oncology. 3, 11, p. 653-654

    Research output: Contribution to journalArticle